Designing Potential Antitrypanosomal Thiazol-2-ethylamines through Predictive Regression Based and Classification Based QSAR Analyses

Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.org..

BACKGROUND: Thiazol-2-ethylamine is recently reported to be an interesting scaffold having antitrypansomal activity for the treatment of sleeping sickness.

METHODS: Statistically significant, robust and validated regression-based QSAR models are constructed for a series of antitrypansomal thiazol-2-ethylamines. Moreover, classification-based QSAR analyses (linear discriminant analysis and Bayesian classification modelling) are also performed to identify the important structural features controlling antitrypanosomal activity.

RESULTS: Molecular fingerprints such as N-piperidinyl and 2-fluorophenyl functions may be responsible for higher antitrypanosomal activity whereas compounds with chlorophenyl moiety and compounds with unsaturated nitrogen atom possess poor activity. These results are supported by the regression-based QSAR model as well as the SAR observations.

CONCLUSION: Finally, fifteen new compounds bearing thiazol-2-ethylamine scaffold are designed and predicted along with their drug-likeness properties. Therefore, this study may provide important structural aspects of designing new antitrypansomal agents with higher activity.

Medienart:

E-Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

Current drug discovery technologies - 14(2017), 1 vom: 18., Seite 39-52

Sprache:

Englisch

Beteiligte Personen:

Amin, Sk Abdul [VerfasserIn]
Adhikari, Nilanjan [VerfasserIn]
Bhargava, Sonam [VerfasserIn]
Jha, Tarun [VerfasserIn]
Gayen, Shovanlal [VerfasserIn]

Links:

Volltext

Themen:

Antiprotozoal Agents
Antitrypansomal agent
Bayesian modeling
Ethylamines
Journal Article
K-MCA
LDA
MLR
QSAR
Research Support, Non-U.S. Gov't
Thiazol-2-ethylamines
Trypanocidal Agents

Anmerkungen:

Date Completed 01.04.2019

Date Revised 01.04.2019

published: Print

Citation Status MEDLINE

doi:

10.2174/1570163813666161117144137

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM266272576